03/21/2023 | Press release | Distributed by Public on 03/21/2023 07:18
As filed with the Securities and Exchange Commission on March 21, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
the Securities Act of 1933
VIGIL NEUROSCIENCE, INC.
(Exact name of registrant as specified in its charter)
Delaware | 83-1880494 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
100 Forge Road, Suite 700
Watertown, MA 02472
(857) 254-4445
(Address, including zip code and telephone number, including area code, of Registrant's principal executive offices)
Vigil Neuroscience, Inc. 2021 Stock Option and Incentive Plan
Vigil Neuroscience, Inc. 2021 Employee Stock Purchase Plan
(Full title of the plans)
Ivana Magovčević-Liebisch
President and Chief Executive Officer
100 Forge Road, Suite 700
Watertown, MA 02472
(857) 254-4445
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Kingsley L. Taft, Esq.
Jacqueline Mercier, Esq.
Gabriela Morales-Rivera, Esq.
Goodwin Procter LLP
100 Northern Avenue
Boston, Massachusetts 02210
(617) 570-1000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
Pursuant to General Instruction E of Form S-8, Vigil Neuroscience, Inc. (the "Registrant") is filing this registration statement with the Commission to register (1) 1,781,016 additional shares of the Registrant's common stock, $0.0001 par value per share ("Common Stock") available for issuance under the Registrant's 2021 Stock Option and Incentive Plan (the "Plan"), pursuant to the evergreen provisions of the Plan, and (2) 286,127 additional shares of Common Stock available for issuance under the Registrant's 2021 Employee Stock Purchase Plan (the "ESPP"), pursuant to the evergreen provisions of the ESPP.
This Registration Statement incorporates by reference the contents of the Registrant's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on January 10, 2022 (File No. 333-262083) related to the Plan and ESPP, except to the extent supplemented, amended or superseded by the information set forth herein. Only those items of Form S-8 containing new information not contained in the earlier Registration Statements are presented herein.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
The exhibits to this Registration Statement are listed in the Exhibit Index attached hereto and incorporated by reference herein.
EXHIBIT INDEX
* |
Filed herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Watertown, State of Massachusetts, on this 21st day of March, 2023.
VIGIL NEUROSCIENCE, INC. |
||
By: | /s/ Ivana Magovčević-Liebisch | |
Name: Ivana Magovčević-Liebisch Title: President and Chief Executive Officer |
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL BY THESE PRESENT, that each individual whose signature appears below hereby constitutes and appoints each of Ivana Magovčević-Liebisch and Jennifer Ziolkowski as such person's true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person's name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following person in the capacities and on the date indicated.
Name | Title | Date | ||
/s/ Ivana Magovčević-Liebisch |
President, Chief Executive Officer, and Director (Principal Executive Officer) |
March 21, 2023 | ||
Ivana Magovčević-Liebisch | ||||
/s/ Jennifer Ziolkowski |
Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer) |
March 21, 2023 | ||
Jennifer Ziolkowski | ||||
/s/ Bruce Booth |
Director, Chairperson |
March 21, 2023 | ||
Bruce Booth | ||||
/s/ Cheryl Renee Blanchard |
Director |
March 21, 2023 | ||
Cheryl Renee Blanchard | ||||
/s/ Mary Thistle |
Director |
March 21, 2023 | ||
Mary Thistle | ||||
/s/ Gerhard Koenig |
Director |
March 21, 2023 | ||
Gerhard Koenig | ||||
/s/ Suzanne Bruhn |
Director |
March 21, 2023 | ||
Suzanne Bruhn | ||||
/s/ Stefan Vitorovic |
Director |
March 21, 2023 | ||
Stefan Vitorovic |